provider portal
Wesper Journal
In this case study, Wesper identifies chronic snoring and menopause-induced insomnia without sleep apnea.Â
Wesper identifies worsening sleep apnea with oral appliance titration. Abstract A 71-year-old woman with a BMI of 26.9 was previously diagnosed with mild sleep apnea and snoring via PSG and was fitted with a mandibular advancement device. After two titrations,...
Continue reading
Wesper consists of two soft, flexible biosensor patches, which adhere to the abdomen and thorax. Wesper connects wirelessly to a mobile device, is rechargeable and reusable, and is extremely user-friendly. The patches collect a wide range of sleep and respiratory...
Continue reading
Through Wesper testing and analysis, the patient received proper treatment and objectively improved overall sleep quality.
Zepbound (tirzepatide) has received FDA approval for the treatment of obstructive sleep apnea, now included in Medicare coverage to help manage the condition alongside obesity. This approval marks a shift towards a holistic approach, combining medication with real-time monitoring for...
Continue reading
